Sikander Ailawadhi

Also affiliated with Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial”.

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30354-9

N/A

3.8DataRank · unranked

126 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Sandi Hita +12 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Blood(2024)10.1182/blood.2024025939

N/A

0.621DataRank · unranked

10 citations

Rachael Sexton, Andrew J. Cowan, Aaron S. Rosenberg, Sikander Ailawadhi, S. Vincent Rajkumar +9 more

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.773958

N/A

0DataRank · unranked

2 citations

Kexun Zhou, Jordan J. Cochuyt, David O. Hodge, Hong Qin, Rami Manochakian +5 more

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms

Blood Cancer Journal(2022)10.1038/s41408-022-00706-5

N/A

0DataRank · unranked

4 citations

Shulan Tian, Susan M. Geyer, Neeraj Sharma, Celine M. Vachon, Yael Kusne +7 more

Randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8054

N/A

0DataRank · unranked

4 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Jason Valent +11 more

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

Blood(2023)10.1182/blood.2023021187

N/A

0DataRank · unranked

14 citations

Shaji Kumar, Linda B. Baughn, Angela Dispenzieri, Patricia T. Greipp, Rhett P. Ketterling +28 more

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

Blood Advances(2024)10.1182/bloodadvances.2023012469

N/A

0DataRank · unranked

21 citations

Sikander Ailawadhi, Ruta Brazauskas, Jinalben Patel, Benjamin Jacobs, Celalettin Üstün +38 more

An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.01.002

N/A

0DataRank · unranked

6 citations

Sikander Ailawadhi, Gabriel Búrbano, Patrick O’Brien, Francis K. Buadi, Suzanne R. Hayman +3 more

Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

UNC Libraries(2024)10.17615/b6zf-nd58

N/A

0DataRank · unranked

0 citations

Benjamin Jacobs, Hemalatha G. Rangarajan, Reinhold Munker, Theresa Hahn, Jinalben Patel +38 more

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study

Blood Cancer Journal(2025)10.1038/s41408-025-01259-z

N/A

0DataRank · unranked

34 citations

Sireesha Asoori, Chiung‐Yu Huang, Larissa Brunaldi, Rakesh Popat, Efstathios Kastritis +19 more

Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.10.003

N/A

0DataRank · unranked

2 citations

Timothy T. Xu, Suheil Albert Atallah‐Yunes, Kenneth J C Lim, Sikander Ailawadhi, Ricardo Parrondo +17 more

Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high-risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8507

N/A

0DataRank · unranked

26 citations

Sikander Ailawadhi, Rachael Sexton, Antje Hoering, Brea Lipe, Sandi Hita +9 more

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

UNC Libraries(2020)10.17615/hhzp-hr83

N/A

0DataRank · unranked

0 citations

Elad Ziv, Wendy Cozen, Andrew F. Olshan, Nathaniel Rothman, Thomas G. Martin +95 more